OptiBiotix Health (LON:OPTI) Stock Price Up 13.3% – Time to Buy?

OptiBiotix Health Plc (LON:OPTI) shares rose 13.3% during mid-day trading on Thursday . The company traded as high as GBX 6.74 and last traded at GBX 6.74. Approximately 676,800 shares traded hands during trading, an increase of 93% from the average daily volume of 350,658 shares. The stock had previously closed at GBX 5.95.

OptiBiotix Health Trading Down 11.0%

The company has a market capitalization of £6.25 million, a PE ratio of -1.58 and a beta of 1.82. The firm’s 50-day simple moving average is GBX 5.79 and its 200-day simple moving average is GBX 5.74.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.